PREDICT score and CYP2C19 polymorphism independently predict lack of efficacy of clopidogrel in cardiology patients-Reference-Cited by-同舟云学术

PREDICT score and CYP2C19 polymorphism independently predict lack of efficacy of clopidogrel in cardiology patients

Published:2016-02-17 Issue:3 Volume:43 Page:379-381
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Mugoša Snežana¹,Djordjević Nataša²,Bukumirić Zoran³,Djukanović Nina⁴,Cukić Jelena⁵,Radosavljević Ivan²,Baskić Dejan²,Protić Dragana³,Zdravković Marija³⁶,Todorović Zoran³⁶

Affiliation:

1. Faculty of Pharmacy; University of Montenegro; Podgorica Montenegro

2. Faculty of Medical Sciences; University of Kragujevac; Kragujevac Serbia

3. Faculty of Medicine; University of Belgrade; Belgrade Serbia

4. High Medical School “Milutin Milanković”; Belgrade Serbia

5. Public Health Institute; Kragujevac Serbia

6. Medical Center “Bežanijska kosa”; Belgrade Serbia

Funder

Ministry of Science, Republic of Serbia

Ministry of Science of Montenegro

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12531/fullpdf

Reference30 articles.

1. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI);Windecker;Eur. Heart J.,2014

2. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC);Steg;Eur. Heart J.,2012

3. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC);Hamm;Eur. Heart J.,2011

4. Thienopyridine resistance among patients undergoing intracoronary stent implantation and treated with dual antiplatelet therapy: assessment of some modifying factors;Djukanovic;J. Pharmacol. Sci.,2008

5. Aspirin and clopidogrel resistance: an emerging clinical entity;Wang;Eur. Heart J.,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives;Expert Opinion on Drug Metabolism & Toxicology;2022-12-02

2. Risk factors for adverse drug reactions associated with clopidogrel therapy;Open Medicine;2022-01-01

3. ABCB1 polymorphism in clopidogrel-treated Montenegrin patients;Open Life Sciences;2021-01-01

4. 9-(4'-dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A2;Medicinal Chemistry;2018-02-06